Insider Transactions in Q3 2021 at Predictive Oncology Inc. (POAI)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2021
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,200
-30.53%
|
$10,200
$1.13 P/Share
|
|
Sep 23
2021
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,334
+49.94%
|
$33,334
$1.13 P/Share
|
|
Sep 13
2021
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jul 01
2021
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,995
+33.65%
|
-
|
|
Jul 01
2021
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+39.94%
|
-
|
|
Jul 01
2021
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+34.37%
|
-
|
|
Jul 01
2021
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+33.64%
|
-
|
|
Jul 01
2021
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
9,924
+34.37%
|
-
|
|
Jul 01
2021
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,995
+35.36%
|
-
|